TGFB ligands play a pivotal role in establishing an immunosuppressive, angiogenic, and pro-tumorigenic TME in gliomas [23,24,29,37,39,53,54], and the upregulation of these ligands in the TME provides for a compelling target for conditioning for an anti-tumor environment. This evidence concerns the gene TGFB1 and glioma.